Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Absence of CD8-positive T cells"
Page 1
The role of CD8+ T cells in endometriosis: a systematic review.
Kisovar A, Becker CM, Granne I, Southcombe JH. Kisovar A, et al. Front Immunol. 2023 Jul 11;14:1225639. doi: 10.3389/fimmu.2023.1225639. eCollection 2023. Front Immunol. 2023. PMID: 37497226 Free PMC article.
RESULTS: 28 published case-control studies and gene set analyses investigating CD8 T cells in endometriosis were included. Data consistently indicate that CD8 T cells are enriched in endometriotic lesions in comparison to eutopic endometrium, with no d …
RESULTS: 28 published case-control studies and gene set analyses investigating CD8 T cells in endometriosis were included. Dat …
A Systematic Review of the Tumor-Infiltrating CD8(+) T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology.
Shadbad MA, Asadzadeh Z, Hosseinkhani N, Derakhshani A, Alizadeh N, Brunetti O, Silvestris N, Baradaran B. Shadbad MA, et al. Front Immunol. 2021 Sep 17;12:734956. doi: 10.3389/fimmu.2021.734956. eCollection 2021. Front Immunol. 2021. PMID: 34603316 Free PMC article.
However, clinical studies have reported controversial results regarding the significance of the tumor-infiltrating CD8(+) T-cells/PD-L1 axis on the clinical picture and the response rate of patients with high-grade glial tumors to anti-cancer therapies. ...Besides, …
However, clinical studies have reported controversial results regarding the significance of the tumor-infiltrating CD8(+) T-cells …
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers.
Hosseinkhani N, Shadbad MA, Asghari Jafarabadi M, Karim Ahangar N, Asadzadeh Z, Mohammadi SM, Lotfinejad P, Alizadeh N, Brunetti O, Fasano R, Silvestris N, Baradaran B. Hosseinkhani N, et al. Int J Mol Sci. 2021 Sep 27;22(19):10389. doi: 10.3390/ijms221910389. Int J Mol Sci. 2021. PMID: 34638729 Free PMC article.
Our results have shown that increased TIGIT expression has been significantly associated with inferior overall survival (OS) (HR = 1.42, 95% CI: 1.11-1.82, and p-value = 0.01). Besides, the level of tumor-infiltrating TIGIT(+)CD8(+) T-cells have been remarkably asso …
Our results have shown that increased TIGIT expression has been significantly associated with inferior overall survival (OS) (HR = 1.42, 95% …
Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis.
Li S, Li L, Pan T, Li X, Tong Y, Jin Y. Li S, et al. Front Immunol. 2022 Sep 21;13:977016. doi: 10.3389/fimmu.2022.977016. eCollection 2022. Front Immunol. 2022. PMID: 36211383 Free PMC article.
BACKGROUND: T-cell immunoreceptor with Ig and ITIM domains (TIGIT) participates in tumor immune escape by delivering inhibitory signals to T cells. The purpose of this article was to assess the prognostic value of TIGIT and its immunological function in solid cancer …
BACKGROUND: T-cell immunoreceptor with Ig and ITIM domains (TIGIT) participates in tumor immune escape by delivering inhibitory signals to …
Circulating biomarkers during progression to type 1 diabetes: A systematic review.
Brenu EW, Harris M, Hamilton-Williams EE. Brenu EW, et al. Front Endocrinol (Lausanne). 2023 Feb 3;14:1117076. doi: 10.3389/fendo.2023.1117076. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36817583 Free PMC article.
An increased risk of T1D progression was associated with the presence of altered gene expression, immune markers including regulatory T cell dysfunction and higher short-lived effector CD8(+) T cells in progressors. DISCUSSION: Several circulating biomarkers are dys …
An increased risk of T1D progression was associated with the presence of altered gene expression, immune markers including regulatory T cell …
CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis.
Ron R, Martínez-Sanz J, Herrera S, Ramos-Ruperto L, Díez A, Sainz T, Álvarez-Díaz N, Correa-Pérez A, Muriel A, López-Alcalde J, Pérez-Molina JA, Moreno S, Serrano-Villar S. Ron R, et al. Front Immunol. 2024 Feb 1;15:1343124. doi: 10.3389/fimmu.2024.1343124. eCollection 2024. Front Immunol. 2024. PMID: 38361925 Free PMC article.